He's no friend of mine. Just saying the high end o
Post# of 72447
(Total Views: 192)
Posted On: 08/16/2017 8:18:05 AM
He's no friend of mine. Just saying the high end of his valuation range is likely what we will be dealing with for Prurisol if we strike a deal after this trial.
$50-$100M upfront, $200-$300M milestones to approval with mid 20% royalties. That's assuming sound confirmation of the percentages we saw in P2A. Could be upside or downside from there. Nobody knows except the IPIX team.
A deal on those terms sends our stock to $10 over night.
Go IPIX!
$50-$100M upfront, $200-$300M milestones to approval with mid 20% royalties. That's assuming sound confirmation of the percentages we saw in P2A. Could be upside or downside from there. Nobody knows except the IPIX team.
A deal on those terms sends our stock to $10 over night.
Go IPIX!
(1)
(0)Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
All my posts are my own personal opinion and speculation. They should not be used as the basis for any investment decision. No, I am not Scottsmith.